News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Korea NIH to Use Affymetrix (Bedford, Massachusetts) (AFFX) Technology for Groundbreaking Genome-Wide Association Study



6/12/2007 1:01:29 PM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that the Republic of Korea’s National Institute of Health (NIH) and Center for Disease Control and Prevention will use the Affymetrix Genome-Wide Human SNP Array 5.0 for the Korean Association REsource (KARE) project. This groundbreaking genome-wide association study is designed to identify the genetic causes of lifestyle-related complex diseases that are prevalent in Korea.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES